Which protocol could you recommend to activate a FLPo (integrated into the AAVS1 locus) with an ERT2 receptor by tamoxifen (4-OHT) in human iPSCs?
The problem with my protocol is the vastly increased cell death.
With what µM of 4-OHT would you start and proceed for how long to ensure cell survival as well as proper activation of the FLPo?
Thanks, for your help in advance!!